Literature DB >> 30459127

Level of serum soluble Tim-3 expression in early-phase acute pancreatitis.

Min Lin1, Jin Huang1, Jian Huang2, Sheng-Lan Liu3, Wei-Chang Chen2.   

Abstract

BACKGROUND/AIMS: T-cell immunoglobulin and mucin domain 3 (Tim-3) assumedly play a crucial immunomodulatory role in inflammatory response. Data on the potential role of soluble Tim-3 (sTim-3) in acute pancreatitis (AP) are scarce. We conducted a prospective clinical study to characterize its role in the early-phase AP.
METHODS: In total, 44 patients with AP (16 mild and 28 none-mild) who presented within 24 hours on admission and 20 healthy volunteers (NC) were included in our study. Serum interleukin (IL)-6, IL-10, tumor necrosis factor (TNF)-α, and sTim-3 levels were detected using enzyme-linked immunosorbent assay (ELISA).
RESULTS: Levels of the pro-inflammatory cytokines IL-6 and TNF-α and the anti-inflammatory cytokine IL-10 in the none-mild and mild groups were significantly elevated compared with those of the NC group. The sTim-3 levels of the none-mild and mild group were significantly increased compared with the NC. The sTim-3 level positively correlated with the IL-6 and TNF-α but showed no obvious correlations with the IL-10 level. The sTim-3 level positively correlated with the APACHE II score.
CONCLUSION: The results indicate that sTim-3 participates in the early progression of AP by positively regulating the pro-inflammatory cytokines and that the measurement of serum sTim-3 is an early marker for predicting AP.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30459127      PMCID: PMC6408170          DOI: 10.5152/tjg.2018.18137

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  24 in total

1.  Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells.

Authors:  Ana C Anderson; David E Anderson; Lisa Bregoli; William D Hastings; Nasim Kassam; Charles Lei; Rucha Chandwaskar; Jozsef Karman; Ee W Su; Mitsuomi Hirashima; Jeffrey N Bruce; Lawrence P Kane; Vijay K Kuchroo; David A Hafler
Journal:  Science       Date:  2007-11-16       Impact factor: 47.728

2.  Tim-3 regulates pro- and anti-inflammatory cytokine expression in human CD14+ monocytes.

Authors:  Ying Zhang; Cheng J Ma; Jia M Wang; Xiao J Ji; Xiao Y Wu; Jonathan P Moorman; Zhi Q Yao
Journal:  J Leukoc Biol       Date:  2011-08-15       Impact factor: 4.962

Review 3.  Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.

Authors:  Shankar Subramanian Iyer; Gehong Cheng
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 4.  [SIRS and CARS: discussion based on the pathologic condition of acute pancreatitis].

Authors:  M Hirota; F Nozawa; A Okabe; M Shibata; K Kuwata; M Ogawa
Journal:  Rinsho Byori       Date:  2000-06

5.  Soluble form of T cell Ig mucin 3 is an inhibitory molecule in T cell-mediated immune response.

Authors:  Hui Geng; Gui-Mei Zhang; Dong Li; Hui Zhang; Ye Yuan; Han-Gang Zhu; Han Xiao; Ling-Fei Han; Zuo-Hua Feng
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

6.  Intra-acinar trypsinogen activation mediates early stages of pancreatic injury but not inflammation in mice with acute pancreatitis.

Authors:  Rajinder Dawra; Raghuwansh P Sah; Vikas Dudeja; Loveena Rishi; Rupjoyti Talukdar; Pramod Garg; Ashok K Saluja
Journal:  Gastroenterology       Date:  2011-08-27       Impact factor: 22.682

Review 7.  Sterile inflammatory response in acute pancreatitis.

Authors:  Rafaz Hoque; Ahsan F Malik; Fred Gorelick; Wajahat Z Mehal
Journal:  Pancreas       Date:  2012-04       Impact factor: 3.327

8.  Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.

Authors:  Peter A Banks; Thomas L Bollen; Christos Dervenis; Hein G Gooszen; Colin D Johnson; Michael G Sarr; Gregory G Tsiotos; Santhi Swaroop Vege
Journal:  Gut       Date:  2012-10-25       Impact factor: 23.059

Review 9.  TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma.

Authors:  E Esposito; S Cuzzocrea
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 10.  Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence.

Authors:  Giuseppe Malleo; Emanuela Mazzon; Ajith K Siriwardena; Salvatore Cuzzocrea
Journal:  Shock       Date:  2007-08       Impact factor: 3.454

View more
  4 in total

1.  Soluble TIM3 and Its Ligands Galectin-9 and CEACAM1 Are in Disequilibrium During Alcohol-Related Liver Disease and Promote Impairment of Anti-bacterial Immunity.

Authors:  Antonio Riva; Elena Palma; Dhruti Devshi; Douglas Corrigall; Huyen Adams; Nigel Heaton; Krishna Menon; Melissa Preziosi; Ane Zamalloa; Rosa Miquel; Jennifer M Ryan; Gavin Wright; Sarah Fairclough; Alexander Evans; Debbie Shawcross; Robert Schierwagen; Sabine Klein; Frank E Uschner; Michael Praktiknjo; Krum Katzarov; Tanya Hadzhiolova; Slava Pavlova; Marieta Simonova; Jonel Trebicka; Roger Williams; Shilpa Chokshi
Journal:  Front Physiol       Date:  2021-03-10       Impact factor: 4.566

2.  Increase in Serum Soluble Tim-3 Level Is Related to the Progression of Diseases After Hepatitis Virus Infection.

Authors:  Lingli Chen; Xiaomei Yu; Chunyan Lv; Yaping Dai; Tao Wang; Shaoxiong Zheng; Yuan Qin; Xiumei Zhou; Yigang Wang; Hao Pei; Hongming Fang; Biao Huang
Journal:  Front Med (Lausanne)       Date:  2022-05-12

3.  Soluble Tim3 detection by time-resolved fluorescence immunoassay and its application in membranous nephropathy.

Authors:  Ming Chen; Liang Wang; Yigang Wang; Xiumei Zhou; Xinyuan Liu; Hao Chen; Biao Huang; Zhigang Hu
Journal:  J Clin Lab Anal       Date:  2020-02-20       Impact factor: 2.352

4.  Assessment of the course of acute pancreatitis in the light of aetiology: a systematic review and meta-analysis.

Authors:  Emese Réka Bálint; Gabriella Fűr; Lóránd Kiss; Dávid István Németh; Alexandra Soós; Péter Hegyi; Zsolt Szakács; Benedek Tinusz; Péter Varjú; Áron Vincze; Bálint Erőss; József Czimmer; Zoltán Szepes; Gábor Varga; Zoltán Rakonczay
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.